International guidelines recommend IV crystalloid as the primary fluid for sepsis resuscitation, with 5% human albumin solution (HAS) as the second line. However, it is unclear which fluid has superior clinical effectiveness. We conducted a trial to assess the feasibility of delivering a randomized controlled trial comparing balanced crystalloid against 5% HAS as sole early resuscitation fluid in patients with sepsis presenting to hospital.

中文翻译：

---

白蛋白与平衡晶体用于脓毒症早期复苏：一项开放平行组随机可行性试验。 ABC-败血症试验。


国际指南推荐静脉注射晶体液作为脓毒症复苏的主要液体，5%人白蛋白溶液（HAS）作为第二线。然而，尚不清楚哪种液体具有更好的临床效果。我们进行了一项试验，以评估进行随机对照试验的可行性，比较平衡晶体与 5% HAS 作为脓毒症入院患者的唯一早期复苏液。